Entero Therapeutics's total assets for Q2 2025 were $85.06M, a decrease of -0.17% from the previous quarter. ENTO total liabilities were $29.68M for the fiscal quarter, a 3.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.